Ventyx Biosciences, Inc. (VTYX) NASDAQ
14.00
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
14.00
+0(+0.00%)
Currency In USD
| Market Cap | 149.97M |
| Enterprise Value | 133.5M |
| P/E Ratio | -9.36 |
| PEG Ratio | -0.87 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 5.22 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -8.65 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.5 |
| Return On Equity | -0.48 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -147.1M |
| Net Income | -135.12M |
| Diluted EPS | -1.97 |
| Total Cash | 192.64M |
| Total Cash/Share | 2.7 |
| Total Debt | 10.02M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 17.86 |
| Book Value Per Share | 2.68 |
| 52-Week Change | 1,300 |
| 52-Week High | 25 |
| 52-Week Low | 0.78 |
| Moving Average 50 Days | 12.84 |
| Moving Average 200 Days | 6.4 |
| Average Volume | 3.81M |
| Shares Outstanding | 71.75M |
| % Held by Institutions | 73.24 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |